MODERN APPROACHES TO STANDARDIZATION OF “VIGITRIL” SUSPENSION BASED ON BISMUTH AND HISTIDINE
Vol. 6 No. 4 Part 2 (2026): Eurasian Journal of Medical and Natural Sciences 214-217
Abstract
This article presents pharmaceutical analysis and standardization methods for “Vigitril” suspension developed on the basis of bismuth, histidine, and ethylenediaminetetraacetic acid. The study investigated physicochemical characteristics, qualitative and quantitative analytical methods, stability parameters, and shelf-life assessment of the dosage form. Modern spectrophotometric and chromatographic approaches were used to determine biologically active compounds in the preparation. The obtained results demonstrated that “Vigitril” suspension complies with pharmacopoeial requirements and possesses promising therapeutic effectiveness.
Keywords:
References
Xusainova R.A. Farmatsevtik tahlil asoslari. – Toshkent, 2021.
Rizaeva N.M. Zamonaviy fizik-kimyoviy tahlil usullari. – Toshkent, 2020.
Marshall B. Helicobacter pylori and peptic ulcer disease. Journal of Medicine, 2005.
O‘zbekiston Respublikasi Davlat Farmakopeyasi. – Toshkent, 2021.
Karimov U.R. Dori vositalarini standartlashtirish. – Toshkent, 2022.
Agilent Technologies. HPLC analytical methods handbook. USA, 2020.
Shimadzu Corporation. UV Spectrophotometry Manual. Japan, 2019.
Xasanov B.X. Gastroprotektiv preparatlar farmakologiyasi. – Toshkent, 2021.
Nurmatov F.K. Vismut preparatlarining zamonaviy tibbiyotdagi o‘rni. Farmatsevtika jurnali, 2022.
O‘zbekiston Respublikasi farmatsevtika tarmog‘ini rivojlantirish konsepsiyasi. – Toshkent, 2021.
Readership
Downloads
Published
Issue
Section
How to Cite
